Rezultati - M. E. Scheulen

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Ultradeep sequencing detects <scp><i>GNAQ</i></scp> and <scp><i>GNA11</i></scp> mutations in cell‐free <scp>DNA</scp> from plasma of patients with uveal melanoma

    Ultradeep sequencing detects <scp><i>GNAQ</i></scp> and <scp><i>GNA11</i></scp> mutations in cell‐free <scp>DNA</scp> from plasma of patients with uveal melanoma od Claudia H.D. Metz, M. E. Scheulen, Norbert Bornfeld, Dietmar Lohmann, Michael Zeschnigk

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery

    Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery od V. Sadony, Michael Körber, Guido Albes, Volker Podtschaske, Thorleif Etgen, Thomas Trösken, Ursula Ravens, M. E. Scheulen

    Izdano 1998
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors

    First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors od K. Mross, Heike Richly, Richard Fischer, Dirk Scharr, Martin Büchert, Angelika C. Stern, Hendrik Gille, Laurent Audoly, M. E. Scheulen

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Risk factors for venous thromboembolic events in cancer patients

    Risk factors for venous thromboembolic events in cancer patients od Knut Kröger, Dorothea Weiland, Claudia Ose, Niklas Neumann, Steven J. Weiss, Calvin H. Hirsch, Krzysztof Urbański, S. Seeber, M. E. Scheulen

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

    Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study od Dirk Strumberg, M. E. Scheulen, Beate Schultheis, Heike Richly, Annette Frost, Martin Büchert, O. Christensen, Michael Jeffers, Roland Heinig, Oliver Boix, K. Mross

    Izdano 2012
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network

    A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central... od K. Mross, Christian Dittrich, Walter E. Aulitzky, Dirk Strumberg, J. Schütte, Roland M. Schmid, S. Hollerbach, Michael Merger, Gerd Munzert, Frank Fleischer, M. E. Scheulen

    Izdano 2012
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

    A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research... od Simone Steinbild, K. Mross, Annette Frost, R. Morant, Silke Gillessen, C. Dittrich, Dirk Strumberg, Andreas Hochhaus, A.-R. Hanauske, Lutz Edler, Iris Burkholder, M. E. Scheulen

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors

    Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors od Sebastian Bauer, R A Hilger, Thomas Mühlenberg, Florian Grabellus, James Nagarajah, Mathias Hoiczyk, Annette Reichardt, Marit Ahrens, Peter Reichardt, Susanne Grünewald, M. E. Scheulen, A. Pustowka, E Bock, Martin Schüler, Daniel Pink

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

    Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid... od Dirk Strumberg, Heike Richly, Ralf A. Hilger, N. Schleucher, Sönke Korfee, Mitra Tewes, Markus Faghih, E. Brendel, D. Voliotis, Claus G. Haase, Brian Schwartz, Ahmad Awada, R. Voigtmann, M. E. Scheulen, S. Seeber

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

    Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors od Heike Richly, Bernhard F. Henning, P. Kupsch, K. Passarge, M. Grubert, Ralf A. Hilger, O. Christensen, E. Brendel, Brian Schwartz, Matthias Ludwig, C. Flashar, R. Voigtmann, M. E. Scheulen, S. Seeber, Dirk Strumberg

    Izdano 2006
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

    Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased r... od Dietrich W. Beelen, Rudolf Trenschel, J. Casper, Mathias Freund, Ralf A. Hilger, M. E. Scheulen, Nadežda Basara, A. A. Fauser, Bernd Hertenstein, H. A. Mylius, Joachim Baumgart, Uwe Pichlmeier, J. Hahn, Ernst Holler

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

    Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial od Serge Leyvraz, Sophie Piperno‐Neumann, Stefan Suciu, J.F. Baurain, Marcin Zdzienicki, Alessandro Testori, Ernest Marshall, M. E. Scheulen, Thomas Jouary, Sylvie Négrier, Jan B. Vermorken, Eckhart Kaempgen, Xavier Durando, Dirk Schadendorf, Ravichandra Karra Gurunath, Ulrich Keilholz

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors

    Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors od Suzanne Leijen, Mark R. Middleton, Patricia Tresca, Françoise Kraeber‐Bodéré, Véronique Dièras, M. E. Scheulen, Avinash Gupta, Vanesa López-Valverde, Zhixin Xu, Ruediger Rueger, Jean Tessier, Eliezer Shochat, Steve Blotner, Valérie Meresse Naegelen, Jan H.M. Schellens, Wilfried Eberhardt

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer

    Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer od Stephen Chan, M. E. Scheulen, S. Johnston, K. Mross, Fátima Cardoso, Christian Dittrich, W. Eiermann, Dagmar Hess, Rudolph Morant, Semiglazov Vf, Markus Borner, Marc Salzberg, Valerijus Ostapenko, H. J. Illiger, Dirk Behringer, Nathalie Bardy‐Bouxin, Joseph Boni, Steven Kong, Maria Cincotta, Laurence Moore

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: